FdaApplication
ANDA 216035
Identifiers
- fda_app_no: ANDA216035
Properties
| Property | Value |
|---|---|
| applicant_name | ALKEM LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2024-08-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RILUZOLE | RILUZOLE | 50MG/10ML | SUSPENSION;ORAL |
1 product